Advertisement

Topics

European Organisation for Research and Treatment of Cancer (EORTC) Company Profile

17:17 EST 10th December 2018 | BioPortfolio

The aims of the European Organisation for Research and Treatment of Cancer (EORTC) are to develop, conduct, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients’ quality of life. Extensive and comprehensive research in this wide field is often beyond the means of individualEuropean laboratories and hospitals, and can best be accomplished through the multidisciplinary, multinational efforts of basic research scientists and clinicians from the European continent. During the last few years, numerous innovative agents have been discovered as a result of tremendous development in the understanding of the molecular basis of cancer. Further clinical progress in cancer
treatment will be accomplished mainly through the conduct of translational research projects, efficient drug development and the execution of large, prospective, randomized, multicenter cancer clinical trials. EORTC promotes multidisciplinary cancer research in Europe and is linked to other leading biomedical research organizations around the world. EORTC has the aim to facilitate the passage of experimental discoveries into state-of-the-art treatment by keeping to a minimum the time lapse between the discovery of new anti-cancer agents and the implementation of their therapeutic benefit for patients with cancer. The ultimate goal of the EORTC is to improve the standard of cancer treatment in Europe, through the development of innovative drugs, and to establish more effective therapeutic strategies, using drugs already commercially available, or surgery and radiotherapy.

Location

Avenue E. Mounier, 83/11
Brussels
1200
Belgium


News Articles [6808 Associated News Articles listed on BioPortfolio]

Media registration now open for 30th EORTC-NCI-AACR symposium

(ECCO-the European CanCer Organisation) Journalists can now register online for the 30th EORTC-NCI-AACR symposium on 'Molecular Targets and Cancer Therapeutics', which takes place in Dublin, Ireland, ...

Combination of two immunotherapies shows activity in non-small cell lung cancer patients

(ECCO-the European CanCer Organisation) A combination of two drugs, which prompt the body's immune system to identify and kill cancer cells, is a safe treatment for patients with advanced non-small ce...

Drug designed to boost radiotherapy for hard-to-treat cancers taken safely by patients

(ECCO-the European CanCer Organisation) A new drug designed to make radiotherapy more effective in treating cancer has been given to patients while they are receiving radiation and shown to be safe, a...

Difficult-to-treat bowel cancers respond in first study of new drug combination

(ECCO-the European CanCer Organisation) Early results from a phase I trial in a small group of patients with advanced cancer using two drugs (nivolumab and pixatimod) that stimulate the immune system ...

The EORTC Brain Tumor Group and Protagen AG Announce Their Collaboration to Investigate the Immuno-Competence of Long-Term Glioblastoma Survivors

The European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group and Protagen AG today announced a collaboration to utilize Protagen’s Cancer Immunothera...

Drug matched to patients according to tumour gene testing shows signs of being effective

(ECCO-the European CanCer Organisation) Treatment with capivasertib, a drug designed to work against a particular gene mutation found in some tumours, shows signs of being effective in a trial of 35 p...

Patients with rare, incurable digestive tract cancers respond to new drug combination

(ECCO-the European CanCer Organisation) Patients with rare, but incurable cancers of the digestive tract have responded well to a combination of two drugs that block the MEK and BRAF pathways, which d...

European Cancer Research gets £30 million vote of confidence

(Cancer Research UK) UK and European research collaborations in cancer research have received a vote of confidence by three major cancer charities, with an announcement today of approximately £30 mil...

PubMed Articles [14537 Associated PubMed Articles listed on BioPortfolio]

The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.

To optimise measurement precision, relevance to patients and flexibility, patient-reported outcome measures (PROMs) should ideally be adapted to the individual patient/study while retaining direct com...

Reference data of the EORTC QLQ-C30 questionnaire: five consecutive annual assessments of approximately 2000 representative Dutch men and women.

Cancer and its treatment have an influence on health-related quality of life (HRQOL). Normative data could help to interpret HRQOL among cancer patients. Our aim was to generate longitudinal normative...

Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma.

Health-related quality of life (HRQOL) is increasingly recognised as an important end-point in cancer clinical trials. The concept of minimally important difference (MID) enables interpreting differen...

Responding to the challenges of international collaborations between the east and the west - report of the first JCOG-EORTC symposium and a perspective from young JCOG and EORTC investigators.

International/intercontinental collaboration is necessary to set up new innovative clinical trials for cancer treatment. However, the infrastructure, especially Asia-Europe academic partnerships, to e...

A Comparison of EORTC And CUETO Risk Tables in Terms of the Prediction of Recurrence and Progression in All Non-Muscle-Invasive Bladder Cancer Patients.

To compare the prediction accuracy of the European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Urology Association for Oncological Treatment (CUETO) risk tables in all no...

Clinical Trials [14441 Associated Clinical Trials listed on BioPortfolio]

European Organisation of Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ) Breast Cancer Module Update

The purpose of this study is to update the EORTC QLQ Breast (BR)-23 Module. Since the development of BR-23 published 1996 the standard therapy of breast cancer has changed. New therapies b...

Validation Study of the Korean Version of the EORTC QLQ-HDC29

The aim of this study is to evaluate the reliability and validity of the Korean version of the European Organization for Research and Treatment of Cancer High-dose Chemotherapy module (EOR...

Clinical Decision-making, Prognosis, Quality of Life and Satisfaction With Care in Patients With Relapsed/Refractory Multiple Myeloma

The primary objective is overall survival (OS) as predicted by baseline self-reported EORTC QLQ-C30 (European Organisation for Research and Treatment of Cancer Quality of Life Questionnair...

Calcium Electroporation for Head and Neck Cancer

In a phase I protocol to primarily investigate the safety of using calcium combined with electroporation on recurrent head and neck cancers. Secondly, to evaluate tumour response on PET/MR...

Quality of Life in Patients With Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cancer-related mortality worldwide. Despite the recent advances in the treatment of HCC, the ...

Companies [4541 Associated Companies listed on BioPortfolio]

European Organisation for Research and Treatment of Cancer (EORTC)

The aims of the European Organisation for Research and Treatment of Cancer (EORTC) are to develop, conduct, coordinate, and stimulate laboratory and clinical research in Europe to improve the manageme...

European Plant Science Organisation

EPSO, the European Plant Science Organisation, is an independent body that represents more than 50 leading Research Institutions from 23 European countries. EPSO wants to improve impact and visibility...

Cancer Treatment Research and Educational Institute

The non-profit Cancer Treatment Research and Educational Institute was founded in 1993 by Karel A. Dicke, M.D., Ph.D. for the purpose of research and education into new developmen...

EURORDIS European Organisation for Rare Diseases

Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc. (OTCBB: BZYR) is a biopharmaceutical company committed to developing treatment for cancer based on genomic and epigenomic principles. Research a...

More Information about "European Organisation for Research and Treatment of Cancer (EORTC)" on BioPortfolio

We have published hundreds of European Organisation for Research and Treatment of Cancer (EORTC) news stories on BioPortfolio along with dozens of European Organisation for Research and Treatment of Cancer (EORTC) Clinical Trials and PubMed Articles about European Organisation for Research and Treatment of Cancer (EORTC) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of European Organisation for Research and Treatment of Cancer (EORTC) Companies in our database. You can also find out about relevant European Organisation for Research and Treatment of Cancer (EORTC) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record